NCT02232321 Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study Status COMPLETED Phase NA
NCT02164214 Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? Status COMPLETED Phase PHASE3
NCT02154425 A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Status COMPLETED Phase PHASE1
NCT02141763 Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis Status COMPLETED Phase PHASE1
NCT02134613 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity Status UNKNOWN Phase PHASE2
NCT02132234 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Status UNKNOWN Phase PHASE4
NCT02103361 Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project Status RECRUITING Phase N/A
NCT02065713 Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients Status COMPLETED Phase PHASE3
NCT02029495 Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis Status TERMINATED Phase PHASE3
NCT02028169 To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA) Status COMPLETED Phase N/A
NCT02024646 Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02019602 A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta Status COMPLETED Phase PHASE1
NCT01989468 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01988103 Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT01965132 Korean College of Rheumatology Biologics and Targeted Therapy Registry Status RECRUITING Phase N/A
NCT01939132 Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis Status UNKNOWN Phase PHASE4